Vivodyne

Overview

Vivodyne is a biotechnology company that focuses on advancing the study of human biology and the development of therapeutics through innovative preclinical drug development. Founded in 2020 by Dr. Andrei Georgescu and Associate Professor Dan Huh, the company aims to enhance drug development by utilizing lab-grown human tissues, providing more predictive and human-relevant data prior to clinical trials.

The company's core innovation combines human tissue engineering, scalable robotics, and advanced artificial intelligence. This integrated platform allows for the generation of predictive human data at an unprecedented scale, enabling safer and more effective drug development. Lab-grown human organs replicate various organ systems in both healthy and diseased states, producing realistic and clinically predictive data essential for identifying new therapeutic targets. Their AI-driven platform autonomously designs and conducts experiments, accelerating the pace of discovery in the biopharmaceutical industry. Vivodyne partners with leading biopharma companies to offer an ethical alternative to traditional animal testing, aligning with regulatory trends toward human-relevant models.

Basic Information

Contact Details

• Phone: +1 267-858-8386
• Website: vivodyne.com
• LinkedIn: linkedin.com/company/vivodyne

Key Focus Areas & Initiatives

• Preclinical drug development using lab-grown human tissues
• Human tissue engineering for predictive data
• Scalable robotics integrated with scientific research workflows
• Use of AI and automation in experimental design and data generation
• Biotechnological research to identify novel therapeutic targets
• Ethical alternatives to animal testing
• Partnerships with biopharmaceutical organizations

Technologies Used

• AI
• Amazon AWS
• Dropbox
• Gmail
• Google Apps
• Google Tag Manager
• IoT
• Microsoft Office 365
• Mobile Friendly
• Remote
• Route 53